Tea nanoparticle, a safe and biocompatible nanocarrier, greatly potentiates the anticancer activity of doxorubicin | Zendy

YiJun Wang | Zendy; Yujian Huang | Zendy; Nagaraju Anreddy | Zendy; Guan-Nan Zhang | Zendy; Yunkai Zhang | Zendy; Meina Xie | Zendy; Derrick Lin | Zendy; DongHua Yang | Zendy; Mingjun Zhang | Zendy; ZheSheng Chen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Tea nanoparticle, a safe and biocompatible nanocarrier, greatly potentiates the anticancer activity of doxorubicin

Author(s) -

YiJun Wang,

Yujian Huang,

Nagaraju Anreddy,

Guan-Nan Zhang,

Yunkai Zhang,

Meina Xie,

Derrick Lin,

DongHua Yang,

Mingjun Zhang,

ZheSheng Chen

Publication year - 2015

Publication title -

oncotarget

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.373

H-Index - 127

ISSN - 1949-2553

DOI - 10.18632/oncotarget.6711

Subject(s) - nanocarriers , doxorubicin , pharmacology , in vivo , cytotoxicity , ex vivo , chemistry , mtt assay , pharmacokinetics , cancer cell , cancer research , in vitro , cancer , medicine , chemotherapy , drug , biology , biochemistry , microbiology and biotechnology

An infusion-dialysis based procedure has been developed as an approach to isolate organic nanoparticles from green tea. Tea nanoparticle (TNP) can effectively load doxorubicin (DOX) via electrostatic and hydrophobic interactions. We established an ABCB1 overexpressing tumor xenograft mouse model to investigate whether TNP can effectively deliver DOX into tumors and bypass the efflux function of the ABCB1 transporter, thereby increasing the intratumoral accumulation of DOX and potentiating the anticancer activity of DOX. MTT assays suggested that DOX-TNP showed higher cytotoxicity toward CCD-18Co, SW620 and SW620/Ad300 cells than DOX. Animal study revealed that DOX-TNP resulted in greater inhibitory effects on the growth of SW620 and SW620/Ad300 tumors than DOX. In pharmacokinetics study, DOX-TNP greatly increased the SW620 and SW620/Ad300 intratumoral concentrations of DOX. But DOX-TNP had no effect on the plasma concentrations of DOX. Furthermore, TNP is a safe nanocarrier with excellent biocompatibility and minimal toxicity. Ex vivo IHC analysis of SW620 and SW620/Ad300 tumor sections revealed evidence of prominent antitumor activity of DOX-TNP. In conclusion, our findings suggested that natural nanomaterials could be useful in combating multidrug resistance (MDR) in cancer cells and potentiating the anticancer activity of chemotherapeutic agents in cancer treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research